Details for Patent: 7,850,990
✉ Email this page to a colleague
Which drugs does patent 7,850,990 protect, and when does it expire?
Patent 7,850,990 protects VYXEOS and is included in one NDA.
This patent has forty-three patent family members in thirteen countries.
Summary for Patent: 7,850,990
Title: | Compositions for delivery of drug combinations |
Abstract: | Compositions which comprise delivery vehicles having stably associated therewith non-antagonistic combinations of two or more agents, such as antineoplastic agents, are useful in achieving non-antagonistic effects when combinations of drugs are administered. |
Inventor(s): | Tardi; Paul (Surrey, CA), Harasym; Troy (North Vancouver, CA), Webb; Murray (North Vancouver, CA), Shew; Clifford (Vancouver, CA), Bally; Marcel (Bowen Island, CA), Mayer; Lawrence (North Vancouver, CA), Janoff; Andrew (Yardley, PA) |
Assignee: | Celator Pharmaceuticals, Inc. (Princeton, NJ) |
Application Number: | 10/417,631 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 7,850,990
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celator Pharms | VYXEOS | cytarabine; daunorubicin | POWDER;INTRAVENOUS | 209401-001 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | FOR THE TREATMENT OF NEWLY-DIAGNOSED THERAPY-RELATED ACUTE MYELOID LEUKEMIA (T-AML) OR AML WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC) IN ADULTS AND PEDIATRIC PATIENTS 1 YEAR AND OLDER | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,850,990
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 345775 | ⤷ Try a Trial | |||
Austria | 475411 | ⤷ Try a Trial | |||
Australia | 2002331480 | ⤷ Try a Trial | |||
Australia | 2002331481 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |